Trademark: 97560126
Status Date
Tuesday, February 13, 2024
Filing Date
Tuesday, August 23, 2022
Published for Opposition
Tuesday, June 27, 2023
5 Pharmaceutical preparations for use in the treatment of neurological and neuro-psychiatric diseases, disorders and conditions; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for treating schizophrenia, major depressive disorder, insomnia, mood disorder, negative symptoms, cognitive disorders, Parkinson's disease; pharmaceutical preparations for blocking serotonin receptors and sigma receptors
Feb 14, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 13, 2024
Sou Extension 1 Granted
Feb 13, 2024
Sou Extension 1 Filed
Feb 13, 2024
Sou Teas Extension Received
Aug 22, 2023
Noa E-Mailed - Sou Required From Applicant
Jun 27, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 27, 2023
Published For Opposition
Jun 7, 2023
Notification Of Notice Of Publication E-Mailed
May 19, 2023
Approved For Pub - Principal Register
May 16, 2023
Teas/Email Correspondence Entered
May 16, 2023
Correspondence Received In Law Office
May 16, 2023
Teas Response To Office Action Received
Apr 19, 2023
Notification Of Non-Final Action E-Mailed
Apr 19, 2023
Non-Final Action E-Mailed
Apr 19, 2023
Non-Final Action Written
Apr 15, 2023
Assigned To Examiner
Sep 12, 2022
New Application Office Supplied Data Entered
Aug 26, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
